Unverified
Gathered automatically from the outlets below; our newsroom hasn't checked it yet.
Amgen drug combined with immunotherapy extends survival in lung cancer trial
Amgen's Imdelltra used in combination with AstraZeneca's immunotherapy Imfinzi reduced the risk of death by 58% compared to the Astra drug alone in patients with extensive-stage small cell lung…